EUROFINS SCIENT EBITDA 2018-2024 | ERFSF
EUROFINS SCIENT annual and quarterly EBITDA history from 2018 to 2024. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
- EUROFINS SCIENT EBITDA for the quarter ending December 31, 2024 was $0M, a 0% increase year-over-year.
- EUROFINS SCIENT EBITDA for the twelve months ending December 31, 2024 was $0M, a 0% increase year-over-year.
- EUROFINS SCIENT 2024 annual EBITDA was $1.46B, a 18.12% increase from 2023.
- EUROFINS SCIENT 2023 annual EBITDA was $1.236B, a 8.57% decline from 2022.
- EUROFINS SCIENT 2022 annual EBITDA was $1.352B, a 33.28% decline from 2021.
| EUROFINS SCIENT Annual EBITDA (Millions of US $) |
|
|---|---|
| 2024 | $1,460 |
| 2023 | $1,236 |
| 2022 | $1,352 |
| 2021 | $2,027 |
| 2020 | $1,407 |
| 2019 | $866 |
| 2018 | $703 |
| 2017 | $553 |
| 2016 | $2,762 |
| 2015 | $0 |
| EUROFINS SCIENT Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2024-12-31 | |
| 2023-06-30 | |
| 2022-12-31 | |
| 2021-12-31 | |
| 2021-06-30 | |
| 2020-12-31 | |
| 2020-06-30 | |
| 2019-12-31 | |
| 2019-06-30 | |
| 2018-12-31 | |
| 2018-06-30 | |
| 2017-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $13.804B | $7.522B |
| Eurofins Scientific SE provides testing services. The company provides food and feed testing, bioanalytical, biopharma, pharma discovery, pharma early development, pharma central laboratory, biopharma product testing, genomic, agroscience, consumer product testing, forensic, environment testing and REACH services. It operates primarily in Benelux, France, Germany, North America, Nordic countries, the United Kingdom, Ireland and internationally. Eurofins Scientific SE is headquartered in Luxembourg. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $143.821B | 26.97 |
| CVS Health (CVS) | United States | $84.326B | 10.48 |
| Elevance Health (ELV) | United States | $78.255B | 10.10 |
| Cencora (COR) | United States | $58.178B | 20.24 |
| DiDi Global (DIDIY) | China | $23.485B | 24.95 |
| Natera (NTRA) | United States | $22.086B | 0.00 |
| Labcorp Holdings (LH) | United States | $21.684B | 17.59 |
| BioMerieux (BMXMF) | France | $16.861B | 0.00 |
| Solventum (SOLV) | United States | $12.836B | 13.59 |
| CochLear (CHEOY) | Australia | $12.824B | 0.00 |
| ICON (ICLR) | Ireland | $12.156B | 11.30 |
| Revvity (RVTY) | United States | $11.802B | 20.31 |
| Viatris (VTRS) | United States | $10.833B | 3.72 |
| Avantor (AVTR) | United States | $9.247B | 13.44 |
| Medpace Holdings (MEDP) | United States | $9.225B | 24.50 |
| HealthEquity (HQY) | United States | $8.646B | 37.87 |
| Sonic Healthcare (SKHHY) | Australia | $8.518B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.808B | 15.30 |
| Caris Life Sciences,�Inc (CAI) | United States | $6.930B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $4.971B | 29.27 |
| BrightSpring Health Services (BTSG) | United States | $3.760B | 34.50 |
| Sotera Health (SHC) | United States | $3.296B | 18.73 |
| Surgery Partners (SGRY) | United States | $2.870B | 37.32 |
| Alignment Healthcare (ALHC) | United States | $2.750B | 0.00 |
| GeneDx Holdings (WGS) | United States | $2.622B | 100.97 |
| Concentras Parent (CON) | United States | $2.619B | 15.13 |
| Organon (OGN) | United States | $2.576B | 2.74 |
| Progyny (PGNY) | United States | $2.038B | 44.87 |
| Ardent Health (ARDT) | United States | $1.981B | 8.45 |
| PACS (PACS) | United States | $1.957B | 0.00 |
| Premier (PINC) | United States | $1.778B | 13.49 |
| GoodRx Holdings (GDRX) | United States | $1.739B | 34.79 |
| Teladoc Health (TDOC) | United States | $1.553B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.303B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.165B | 8.86 |
| CareDx (CDNA) | United States | $1.129B | 17.64 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
| Agilon Health (AGL) | United States | $0.948B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.846B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.833B | 7.80 |
| Nutex Health (NUTX) | United States | $0.643B | 9.73 |
| Embecta (EMBC) | United States | $0.619B | 4.17 |
| InnovAge Holding (INNV) | United States | $0.571B | 0.00 |
| SBC Medicals (SBC) | United States | $0.546B | 0.00 |
| LifeMD (LFMD) | United States | $0.535B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.484B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.471B | 10.62 |
| So-Young (SY) | China | $0.440B | 0.00 |
| Omada Health (OMDA) | $0.434B | 0.00 | |
| Enhabit (EHAB) | United States | $0.368B | 30.29 |
| Performant Healthcare (PHLT) | United States | $0.335B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.330B | 0.00 |
| Beauty Health (SKIN) | United States | $0.263B | 0.00 |
| Oncology Institute (TOI) | United States | $0.216B | 0.00 |
| DocGo (DCGO) | United States | $0.159B | 26.00 |
| Pheton Holdings (PTHL) | China | $0.132B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.100B | 0.00 |
| KindlyMD (NAKA) | United States | $0.074B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.067B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.062B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| ModivCare (MODV) | United States | $0.060B | 0.00 |
| Biodesix (BDSX) | United States | $0.046B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.037B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.024B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.013B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |